Tomás Artaza

Recompensation Following Alcohol-Related Hepatitis Is Associated With Increased Survival: Results From a Multicenter Study

Jordi Gratacós-Ginès, Pilar Ruz-Zafra, Queralt Herms, Miriam Celada-Sendino et autres

es (code pays fourni par la source)

107 - LA SUPERVIVENCIA EN PACIENTES CON HEPATITIS ASOCIADA AL ALCOHOL DIFIERE SEGÚN EL SUBTIPO DE MELD

Jordi Gratacós-Ginès, Álvaro Giráldez-Gallego, Miriam Celada-Sendino, Ares Villagrasa et autres

DESARROLLO DE HIPERTENSIÓN PORTAL TRAS UNA TROMBOSIS PORTAL AGUDA (TPA) NO CIRRÓTICA Y NO TUMORAL. ESTUDIO MULTICÉNTRICO VALDIG

Berta Bartrolí-Alabau, Aurélie Plessier, F. Martinón Sánchez, Audrey Payance et autres

GS-004 Development of portal hypertension after non-cirrhotic non-tumoral recent portal vein thrombosis (RPVT). A long-term follow-up study

Berta Bartrolí Alabau, Aurélie Plessier, F. Martinón Sánchez, Audrey Payancé et autres

THU-411 Long term liver-related events in patients with HCV-related liver disease and advanced fibrosis after sustained virological response with direct-acting antivirals

Jorge Barajas, Tomás Artaza, JuanJosé Sánchez-Ruano, Marta Romero-Gutiérrez et autres

SAT-257 Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)

Jordi Gratacós‐Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, Aina Martí et autres

SAT-267 The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)

Jordi Gratacós‐Ginès, María Del Barrio, Pilar Ruz-Zafra, Miriam Celada-Sendino et autres

Recurrent alcohol-associated hepatitis is common and is associated with increased mortality

Jordi Gratacós‐Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, Aina Martí‐Carretero et autres

BACKGROUND AND AIMS: Alcohol relapse after surviving an episode of alcohol-associated hepatitis (AH) is common. However, the clinical features, risk factors, and prognostic implications of recurrent alcohol-associated hepatitis (RAH) are not well described. APPROACH AND RESULTS: A registry-based study was done of …

es (code pays fourni par la source)

Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis

Antonio Guerrero, Fabio Piscaglia, Bernhard Scheiner, Guohong Han et autres

es, it, at, cn, pt, gb (code pays fourni par la source)

Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis

Tomás Artaza, Miriam Ghedini Garcia Lopes, Marta Romero-Gutiérrez, Ana-Zaida Gómez et autres

es (code pays fourni par la source)

Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis

Tomás Artaza, Miriam Ghedini Garcia Lopes, Marta Romero-Gutiérrez, A. Caro-Patón Gómez et autres

es (code pays fourni par la source)

Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment

Tomás Artaza, Miriam Ghedini Garcia Lopes, Marta Romero-Gutiérrez, Juan José Sánchez et autres

Portal vein thrombosis (PVT) is considered a common complication of liver cirrhosis. Its prevalence increases with liver disease severity, reaching 25% in patients awaiting liver transplantation (LT). The majority of patients with cirrhosis are diagnosed incidentally with PVT during routine ultrasound in …

es (code pays fourni par la source)